“Comparative Efficacy of Tirzepatide, Teneligliptin, and Empagliflozin in HbA1c Reduction in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis”, Int J Med Surg Sci, vol. 10, no. 3, pp. 1–18, Sep. 2023, doi: 10.32457/ijmss.v10i3.2263.